Accountability in Research

Drug Development: Ethics and Public Confidence is a Must

University of Maryland School of Medicine USA

Dr. Shamoo is the Founder & Editor - Chief (Since 1988) of the journal, Accountability in Research and a member of several boards among them the editorial board of the Drug Information Journal (2005-present) and advisory board of 2005-2007 of: Public Library of Science, Clinical Trials (PLos Clinical Trials).

Adil Shamoo, Ph.D

Confronting the Compliance Myth: How can we Really Protect Human Subject?

Department of Anesthesia and Critical Care, USA

Dr. Koski is currently Senior Scientist at the Institute for Health Policy at the Masschusetts, Harvard Medical School. Dr. Koski chairs the Ethics Advisory board of the National Heart Lung and Blood Institute's renowned Framingham Heart Study and the chair person for the advisory board of the Strategic Initiative for Developing Capacity for Ethical Review based at the WHO.

Greg Koski, Ph.D, MD

Ethical Decision Making in Clinical Research Management…Listening to your Moral Imperative

Vice President of Human Research Technology Inc. USA

Mr. Koscin serves as the Lead Forum Chair for the Association of Clinical Research Professional (ACRP) special interest forums, an active member of the ACRP Marketing & Communication Committee and the Lead Instructor for the certificate course Pathways in Clinical Research.

Mark Koscin, M.T., CCRA, ACRP

Exploring Ethical Issues Beyond Good Clinical (Research) Practice

Former Vice President
GlaxoSmithKline, USA

Mr. Tom Merchant is an attorney and the former Vice President of R&D Legal Risk Management at GlaxoSmithKline Pharmaceutical in Suburban Philadelphia. He recently led a US/UK based group responsible for auditing worldwide R&D risk which have a significant legal component or pose significant risk reputation.

Thomas E. Merchant, ESQ